Scott Terrillion - 30 Aug 2021 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Sec'y; Chief Compliance & G.C.
Signature
/s/ Darren DeStefano, Attorney-in-Fact
Issuer symbol
CARA
Transactions as of
30 Aug 2021
Net transactions value
-$24,978
Form type
4
Filing time
01 Sep 2021, 18:09:41 UTC
Previous filing
26 Aug 2021
Next filing
21 Dec 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Sale $24,978 -1,759 -2.4% $14.20* 70,917 30 Aug 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was effected pursuant to a "sell to cover" arrangement adopted by the Reporting Person in accordance with Rule 10b5-1 on September 6, 2018 to satisfy the tax withholding obligations triggered by the vesting of RSUs reported in the Form 4 filed with the Securities and Exchange Commission on August 26, 2021, and does not represent a discretionary trade by the Reporting Person.